EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Huashi Baidu granules alleviate LPS-induced endothelial injury by modulating the AKT1-FOXO3a signaling pathway

Chuanxi Tian, Jinyue Zhao, Tianyi Lyu, Rui Hao, Jiarui Li, Li Wan, Mengjiao Kang, Shuang Zhao, Ziqing Yang, Shuyi Feng, Qian Wang, Min Li

Phytomedicine · 2025

DOI: 10.1016/j.phymed.2025.157372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Chuanxi Tian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China; National Center for Integrative Medicine, China-Japan Friend…. Hauptthemen laut MEDLINE: Forkhead Box Protein O3, Proto-Oncogene Proteins c-akt, Drugs, Chinese Herbal, Acute Lung Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Peking University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Huashi Baidu granules (HSBD) are a proprietary Chinese medicine demonstrated to be effective in treating COVID-19 patients. Although HSBD has shown promising clinical efficacy, its mechanism of endothelial protection remains unclear. PURPOSE: This study aimed to elucidate the mechanism by which HSBD alleviates endothelial injury in acute lung injury (ALI). METHODS: A lipopolysaccharide (LPS)-induced ALI mouse model and HUVECs were used to investigate the endothelial protective effects of HSBD. Proteomic analysis of lung tissue was conducted to explore the underlying mechanisms. Hematoxylin and eosin (H&E) staining, Evans blue albumin (EBA) leakage assays, ELISA, endothelial permeability assays, Western blotting (WB), qRT-PCR and Immunofluorescence (IF) were employed to assess endothelial injury and identify relevant signaling pathways. RESULTS: HSBD significantly ameliorated histopathological lung injury and reduced endothelial permeability, as evidenced by EBA staining and lung tissue fluorescence imaging. HSBD also suppressed the expression of IL-6, TNF-α, and IL-1β in both serum and lung tissue. Proteomics analysis revealed enrichment of differentially expressed proteins in the FOXO signaling pathway. Western blotting and qRT-PCR confirmed that HSBD downregulated phosphorylated AKT1 and FOXO3a levels, while upregulating VE-cadherin (cadherin-5) expression both in vitro and in vivo, immunofluorescence of mouse lung sections corroborated these findings. By showing that the AKT activator SC79 blocked the protective effects of HSBD, our results indicate that AKT1 activation is essential for HSBD's action against endothelial injury. CONCLUSION: Collectively, these findings demonstrate that HSBD mitigates LPS-induced endothelial injury by modulating the AKT1-FOXO3a signaling pathway, offering mechanistic insight into its potential therapeutic role in COVID-19 from an endothelial protection perspective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Forkhead Box Protein O3Proto-Oncogene Proteins c-aktDrugs, Chinese HerbalAcute Lung InjuryAnimalsSignal TransductionLipopolysaccharidesMiceHumansMaleHuman Umbilical Vein Endothelial CellsMice, Inbred C57BLCadherinsDisease Models, AnimalLungAntigens, CDCadherin 5

Stichwörter der Autor:innen

ALICOVID-19Endothelial damageHuashi Baidu granules

Substanzen

Forkhead Box Protein O3Proto-Oncogene Proteins c-aktLipopolysaccharidesDrugs, Chinese HerbalCadherinsAntigens, CDCadherin 5FoxO3 protein, mouseAkt1 protein, mouseFOXO3 protein, human

Autor:innen und Institutionen

  • Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China; National Center for Integrative Medicine, China-Japan Friendship Hospital, Beijing, 100192, China.
  • Graduate School, Changchun University of Chinese Medicine, Changchun, 130117, China.
  • Department of Acupuncture, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, 100026, China.
  • Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
  • Zhejiang University of Traditional Chinese Medicine, Zhejiang, Hangzhou, 310053, China.
  • National Center for Integrative Medicine, China-Japan Friendship Hospital, Beijing, 100192, China.

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Peking University
  • National Key Research and Development Program of China

Zitieren

APA

Tian, C., Zhao, J., Lyu, T., Hao, R., Li, J., Wan, L., Kang, M., Zhao, S., Yang, Z., Feng, S., Wang, Q., & Li, M. (2025). Huashi Baidu granules alleviate LPS-induced endothelial injury by modulating the AKT1-FOXO3a signaling pathway. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157372

Vancouver

Tian C, Zhao J, Lyu T, Hao R, Li J, Wan L, et al. Huashi Baidu granules alleviate LPS-induced endothelial injury by modulating the AKT1-FOXO3a signaling pathway. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157372

BibTeX
@article{Tian2025,
  author = {Tian, Chuanxi and Zhao, Jinyue and Lyu, Tianyi and Hao, Rui and Li, Jiarui and Wan, Li and Kang, Mengjiao and Zhao, Shuang and Yang, Ziqing and Feng, Shuyi and Wang, Qian and Li, Min},
  title = {Huashi Baidu granules alleviate LPS-induced endothelial injury by modulating the AKT1-FOXO3a signaling pathway},
  journal = {Phytomedicine},
  year = {2025},
  doi = {10.1016/j.phymed.2025.157372}
}
Kostenlos starten →